Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GISTAR: H. pylori Eradication and Pepsinogen Testing for Gastric Cancer Prevention
NCT02047994Phase 4Recruiting
- Sponsor
- International Agency for Research on Cancer
- Start
- Mar 2013
- Primary completion
- Dec 2033
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of esomeprazole, clarithromycin and amoxicillin in Helicobacter pylori infection, sponsored by International Agency for Research on Cancer. Primary endpoint: Gastric cancer mortality at 15 years. Started Mar 2013; status: recruiting.
02
Drugs
esomeprazoleclarithromycinamoxicillin
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on NCT02047994.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02047994.